Manuel Serrano × Epigenetic Rejuvenation
Manuel Serrano's in vivo reprogramming research connects to epigenetic rejuvenation through a reported ImAge reduction after transient OSKM expression in liver and skeletal muscle, though the organism, experimental design, and tissue function outcomes remain unspecified.
Manuel Serrano leads a research group at IRB Barcelona (a research institute in Barcelona). His work covers cellular senescence, tissue plasticity, and in vivo reprogramming (reprogramming cells inside a living organism). These areas overlap with epigenetic rejuvenation, a class of interventions aimed at restoring younger cellular or tissue states by resetting age-linked epigenetic and transcriptional programs.
The link comes from a specific experimental finding: transient expression of OSKM (a set of reprogramming factors) reduced a measure called ImAge in liver and skeletal muscle. OSKM reprogramming has been described as an approach to tissue regeneration and rejuvenation, but it is unclear what ImAge captures, how durable the decrease was, what organism was used, or what the experimental design looked like. Tissue function outcomes are not described. Serrano's specific contribution to this experiment is not stated either.
The key question for the primary source: did tissue function improve alongside the metric, or did only the metric change?
The edge is grounded in a concrete experimental observation that sits at the intersection of Serrano's in vivo reprogramming work and the epigenetic rejuvenation intervention class. Several key details are unestablished, making this a connection that signals exactly where primary-source verification is needed rather than settling the question.